Search

Kan Yuen

Examiner (ID: 1077, Phone: (571)270-1413 , Office: P/2464 )

Most Active Art Unit
2464
Art Unit(s)
2616, 2416, 2464
Total Applications
985
Issued Applications
824
Pending Applications
63
Abandoned Applications
114

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9896011 [patent_doc_number] => 20150051210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'Tyrosine Kinase Inhibitor Combinations and their Use' [patent_app_type] => utility [patent_app_number] => 14/388251 [patent_app_country] => US [patent_app_date] => 2013-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11631 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388251 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/388251
Tyrosine Kinase Inhibitor Combinations and their Use Mar 31, 2013 Abandoned
Array ( [id] => 9865433 [patent_doc_number] => 20150045452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'METHOD FOR PRODUCING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, AND ORALLY DISINTEGRATING TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE' [patent_app_type] => utility [patent_app_number] => 14/384358 [patent_app_country] => US [patent_app_date] => 2013-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9771 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14384358 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/384358
METHOD FOR PRODUCING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, AND ORALLY DISINTEGRATING TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE Mar 26, 2013 Abandoned
Array ( [id] => 9865433 [patent_doc_number] => 20150045452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'METHOD FOR PRODUCING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, AND ORALLY DISINTEGRATING TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE' [patent_app_type] => utility [patent_app_number] => 14/384358 [patent_app_country] => US [patent_app_date] => 2013-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9771 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14384358 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/384358
METHOD FOR PRODUCING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, AND ORALLY DISINTEGRATING TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE Mar 26, 2013 Abandoned
Array ( [id] => 9397078 [patent_doc_number] => 20140094484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-03 [patent_title] => 'SUSTAINED DELIVERY FORMULATIONS OF RAPAMYCIN COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/633572 [patent_app_country] => US [patent_app_date] => 2012-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 24332 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13633572 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/633572
SUSTAINED DELIVERY FORMULATIONS OF RAPAMYCIN COMPOUNDS Oct 1, 2012 Abandoned
Array ( [id] => 7767101 [patent_doc_number] => 20120034682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Process for Separating High Purity Germ and Bran from Corn' [patent_app_type] => utility [patent_app_number] => 13/273572 [patent_app_country] => US [patent_app_date] => 2011-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4415 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034682.pdf [firstpage_image] =>[orig_patent_app_number] => 13273572 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/273572
Process for Separating High Purity Germ and Bran from Corn Oct 13, 2011 Abandoned
Array ( [id] => 8990508 [patent_doc_number] => 20130217789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'BIODEGRADABLE LIQUOGEL AND PH SENSITIVE NANOCARRIERS' [patent_app_type] => utility [patent_app_number] => 13/818782 [patent_app_country] => US [patent_app_date] => 2011-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 10958 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818782 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/818782
BIODEGRADABLE LIQUOGEL AND PH SENSITIVE NANOCARRIERS Sep 1, 2011 Abandoned
Array ( [id] => 7776545 [patent_doc_number] => 20120039991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'USE OF APOPTOSIS INHIBITING COMPOUNDS IN DEGENERATIVE NEUROLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/211832 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13921 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039991.pdf [firstpage_image] =>[orig_patent_app_number] => 13211832 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/211832
USE OF APOPTOSIS INHIBITING COMPOUNDS IN DEGENERATIVE NEUROLOGICAL DISORDERS Aug 16, 2011 Abandoned
Array ( [id] => 7657329 [patent_doc_number] => 20110306598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Use of the association of a sinus node if current inhibitor and an angiotensin-converting enzyme inhibitor in the treatment of heart failure' [patent_app_type] => utility [patent_app_number] => 13/134667 [patent_app_country] => US [patent_app_date] => 2011-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3061 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306598.pdf [firstpage_image] =>[orig_patent_app_number] => 13134667 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/134667
Use of the association of a sinus node if current inhibitor and an angiotensin-converting enzyme inhibitor in the treatment of heart failure Jun 13, 2011 Abandoned
Array ( [id] => 7657273 [patent_doc_number] => 20110306542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'NOVEL GLP-1 RECEPTOR STABILIZERS AND MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/157264 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25715 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306542.pdf [firstpage_image] =>[orig_patent_app_number] => 13157264 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/157264
GLP-1 receptor stabilizers and modulators Jun 8, 2011 Issued
Array ( [id] => 6070694 [patent_doc_number] => 20110045544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Treatment of Cellulosic Material and Enzymes Useful Therein' [patent_app_type] => utility [patent_app_number] => 12/917603 [patent_app_country] => US [patent_app_date] => 2010-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 31097 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045544.pdf [firstpage_image] =>[orig_patent_app_number] => 12917603 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/917603
Treatment of cellulosic material and enzymes useful therein Nov 1, 2010 Issued
Array ( [id] => 5997061 [patent_doc_number] => 20110016542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'CANINE GENOME EDITING WITH ZINC FINGER NUCLEASES' [patent_app_type] => utility [patent_app_number] => 12/842839 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12521 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20110016542.pdf [firstpage_image] =>[orig_patent_app_number] => 12842839 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/842839
CANINE GENOME EDITING WITH ZINC FINGER NUCLEASES Jul 22, 2010 Abandoned
Array ( [id] => 8146882 [patent_doc_number] => 08163892 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Oncolytic virus replicating selectively in tumor cells' [patent_app_type] => utility [patent_app_number] => 12/839264 [patent_app_country] => US [patent_app_date] => 2010-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8571 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163892.pdf [firstpage_image] =>[orig_patent_app_number] => 12839264 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/839264
Oncolytic virus replicating selectively in tumor cells Jul 18, 2010 Issued
Array ( [id] => 6149306 [patent_doc_number] => 20110020901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/821686 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26154 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020901.pdf [firstpage_image] =>[orig_patent_app_number] => 12821686 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/821686
Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof Jun 22, 2010 Abandoned
Array ( [id] => 6125724 [patent_doc_number] => 20110086105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'METHODS FOR IDENTIFYING NOVEL NUCLEIC ACID REGULATORY ELEMENTS AND COMPOUNDS THAT AFFECT THE REGULATION' [patent_app_type] => utility [patent_app_number] => 12/781308 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7541 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086105.pdf [firstpage_image] =>[orig_patent_app_number] => 12781308 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/781308
METHODS FOR IDENTIFYING NOVEL NUCLEIC ACID REGULATORY ELEMENTS AND COMPOUNDS THAT AFFECT THE REGULATION May 16, 2010 Abandoned
Array ( [id] => 6567283 [patent_doc_number] => 20100223683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Isolated Polynucleotide Sequence with IRES Activity' [patent_app_type] => utility [patent_app_number] => 12/778408 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8049 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20100223683.pdf [firstpage_image] =>[orig_patent_app_number] => 12778408 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/778408
Isolated Polynucleotide Sequence with IRES Activity May 11, 2010 Abandoned
Array ( [id] => 6007868 [patent_doc_number] => 20110059899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Kruppel-like factor 6 (KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein' [patent_app_type] => utility [patent_app_number] => 12/769595 [patent_app_country] => US [patent_app_date] => 2010-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26428 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059899.pdf [firstpage_image] =>[orig_patent_app_number] => 12769595 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/769595
Kruppel-like factor 6 (KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein Apr 27, 2010 Abandoned
Array ( [id] => 7711876 [patent_doc_number] => 20120004199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'SCAFFOLDS' [patent_app_type] => utility [patent_app_number] => 13/255688 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10073 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255688 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/255688
SCAFFOLDS Mar 9, 2010 Abandoned
Array ( [id] => 8555410 [patent_doc_number] => 08329882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Genetic control of mammalian cells with synthetic RNA regulatory systems' [patent_app_type] => utility [patent_app_number] => 12/708506 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17312 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12708506 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/708506
Genetic control of mammalian cells with synthetic RNA regulatory systems Feb 17, 2010 Issued
Array ( [id] => 5943518 [patent_doc_number] => 20110104138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'USE OF THE INNATE IMMUNITY GENE OASL FOR PREVENTING OR TREATING INFECTION WITH NEGATIVE STRAND RNA VIRUSES' [patent_app_type] => utility [patent_app_number] => 12/611746 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18679 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104138.pdf [firstpage_image] =>[orig_patent_app_number] => 12611746 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/611746
USE OF THE INNATE IMMUNITY GENE OASL FOR PREVENTING OR TREATING INFECTION WITH NEGATIVE STRAND RNA VIRUSES Nov 2, 2009 Abandoned
Array ( [id] => 6333976 [patent_doc_number] => 20100115641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'GFP-TRANSFECTED CLON PIG, GT KNOCK-OUT CLON PIG AND METHODS FOR PRODUCTIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/579032 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9113 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20100115641.pdf [firstpage_image] =>[orig_patent_app_number] => 12579032 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/579032
GFP-TRANSFECTED CLON PIG, GT KNOCK-OUT CLON PIG AND METHODS FOR PRODUCTIONS THEREOF Oct 13, 2009 Abandoned
Menu